Homing of in vitro-generated donor antigen-reactive CD4+ T lymphocytes to renal allografts is α4β1 but not αLβ2 integrin dependent

Journal of Immunology

Volumn 166, Issue 1, 2001, Pages 596-601

  Hammer, M H ^a   Zhai, Y ^a   Katori, M ^a   Ritter, T ^a   Volk, H D ^a   Coito, A J ^a   Kupiec Weglinski, J W ^a  

^a UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CD4 ANTIGEN; INTEGRIN; INTEGRIN RECEPTOR; MONOCLONAL ANTIBODY; SCLEROPROTEIN; T LYMPHOCYTE RECEPTOR;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GRAFT REJECTION; KIDNEY ALLOGRAFT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

EID: 0035159648     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.1.596     Document Type: Article

References (30)

1. + T cell-mediated rejection of major histocompatibility complex class I-disparate grafts: A role for alloantibody
2. Acute rejection
3. Distinct migration patterns of naive and effector CD8 T cells in the spleen: Correlation with CCR7 receptor expression and chemokine reactivity
4. + T cell lines
5. The impact of immunosuppressive drugs on the analysis of T cell activation
6. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney: Inhibition by soluble P-selectin
7. Differentiation and functions of T cell subsets
8. The CD40 pathway in allograft rejection, acceptance, and tolerance
9. T helper frequencies in peripheral blood reflect donor-directed reactivity in the graft after clinical heart transplantation
10. Evidence that human cardiac allograft acceptance is associated with a decrease in donor-reactive helper T lymphocytes
11. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
12. + T cells
13. The CD44-initiated pathway of T-cell activation uses VLA-4 but not LFA-1 for firm adhesion
14. Two integrin binding peptides abrogate T cell-mediated immune responses in vivo
15. The integrin VLA-4 supports tethering and rolling in flow on VCAM-1
16. 4 integrins is cell-type specific and activation dependent and is disrupted during apoptosis in T cells
17. 4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment
18. + T lymphocytes
19. Fibronectin-mononuclear cell interactions regulate type 1 helper T cell cytokine network in tolerant transplant recipients
20. Lymphocyte migration patterns in organ allograft recipients
21. Potential of allospecific gene-engineered T cells in transplantation gene therapy: Specific T-cell activation determines transgene expression in vitro and in vivo
22. Induction of "infectious" tolerance to MHC-incompatible cardiac allografts in CD4 mAb-treated sensitized rat recipients
23. Heterogeneity of lymphocyte homing physiology: Several mechanisms operate in control of migration to lymphoid and nonlymphoid organs in vivo
24. + T cells
25. Endothelial activation and chronic allograft rejection
26. Distribution of activated T cells migrating through the body: A matter of life and death
27. Blockade of very late antigen-4 integrin binding to fibronectin in allograft recipients. I. Treatment with connecting segment-1 peptides prevents acute rejection by suppressing intragraft mononuclear cell accumulation, endothelial activation, and cytokine expression
28. Anti-integrin (LFA-1, VLA-4, and Mac-1) antibody treatment and acute cardiac graft rejection in the rat
29. Prolongation of rat islet allograft survival by treatment with monoclonal antibodies against VLA-4 and LFA-1
30. CD28 and LFA-1 contribute to cyclosporine A-resistant T cell growth by stabilizing the IL-2 mRNA through distinct signaling pathways